Enshaei, Amir <br/><br/>
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.  [electronic resource] 

 -  Blood  04 2020 
 - 1438-1446 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood.2019003191  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Biomarkers, Tumor--analysis<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infant<br/>Male<br/>Neoplasm Recurrence, Local--pathology<br/>Neoplasm, Residual--pathology<br/>Outcome Assessment, Health Care--statistics & numerical data<br/>Patient Selection<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--pathology<br/>Prognosis<br/>Retrospective Studies<br/>Risk Factors<br/>Survival Rate